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As opposed to the two-thirds of individuals with epilepsy who have optimal seizure control, intractable epilepsy is associated with high rates of anxiety and depression, poor quality of life, and cognitive problems. These comorbidities constitute stresses that may worsen seizure frequency, creating a vicious cycle. In a prospective evaluation of inpatients with intractable epilepsy, 54% had depression and 19% had suicidal thoughts (1) . In that study, depression was found to be a much more powerful predictor of the quality of life than other variables, including duration of epilepsy, number of antiseizure medications, and even seizure frequency itself. Therefore, treatment of comorbidities of intractable epilepsy, especially affective ones, ought to have similar priority to, and actually intersects with, treating seizures.
Mindfulness meditation is a practice that aims at cultivating awareness of the present moment in a nonjudgmental manner. Meditation practice involves focusing on one's breath or other currently present stimuli, and disengaging from dwelling on past events or future planning, and from strong attachments to beliefs or emotions. Mindfulness has been shown to have numerous therapeutic effects, including affect regulation, in many studies (2) . Moreover, it was even found to have measureable neurophysiologic effects. One study found that 8 weeks of mindful meditation could increase left-sided anterior activation on EEG, a pattern associated with positive affect, and meditators were found to have higher antibody titers to the influenza vaccine (3). This increase was predicted by the magnitude of increase in left-sided activation. A number of other studies have confirmed the positive effect of mindfulness meditation on brain and immune functions. Interestingly, four randomized control trials concluded that mindfulness meditation can increase telomerase activity in white blood cells, suggesting that meditation might promote cell longevity and slow aging (4) . Therefore, mindfulness is likely to be particularly helpful in epilepsy. Like most chronic illnesses, epilepsy can be worsened by modifiable lifestyle factors. Therefore, strengthening the patients' moment-by-moment awareness of measures that optimize their health is of key importance. Equally important is improving the patients' attitude toward their seizures and the lifestyle that is shaped by epilepsy. Coping with stress can lead to proper education about seizures and epilepsy, avoiding seizure triggers, and strict adherence to the antiseizure medication regimen.
Tang et al. (5) conducted an assessor-blinded randomized controlled trial to compare the effects of mindfulness therapy plus social support with those of social support alone in subjects with intractable epilepsy. Of the 60 recruited subjects, 37% had severe anxiety and 23% had depression. The primary outcome measure of the trial was the change in the total score of the Patient-Weighted Quality of Life in Epilepsy Inventory OBJECTIVE: To investigate the effectiveness of mindfulness-based therapy (MT) and social support (SS) in patients with drug-resistant epilepsy. METHODS: We performed an assessor-blinded randomized control trial. Sixty patients with drug-resistant epilepsy were randomly allocated to MT or SS (30 per group). Each group received 4 biweekly intervention sessions. The primary outcome was the change in the total score of the Patient-Weighted Quality of Life in Epilepsy Inventory (QOLIE-31-P). Secondary outcomes included seizure frequency, mood symptoms, and neurocognitive functions. The assessors were blinded to the patient's intervention grouping. Results were analyzed using general linear model with repeated measure. RESULTS: Following intervention, both the MT (n=30) and SS (n=30) groups had an improved total QOLIE-31-P, with an improvement of +6.23 for MT (95% confidence interval [CI] +4.22 to +10.40) and +3.30 for SS (95% CI +1.03 to +5.58). Significantly more patients in the MT group had a clinically important improvement in QOLIE-31-P (+11.8 or above) compared to those who received SS (11 patients vs. 4 patients). Significantly greater reduction in depressive and anxiety symptoms, seizure frequency, and improvement in delayed memory was observed in the MT group compared with the SS group. CONCLUSIONS: We found benefits of short-term psychotherapy on patients with drug-resistant epilepsy. Mindfulness therapy was associated with greater benefits than SS alone in quality of life, mood, seizure frequency, and verbal memory. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that mindfulness-based therapy significantly improves quality of life in patients with drug-resistant epilepsy.
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(QOLIE-31-P). As secondary outcome measures, the authors assessed seizure control, mood, and cognition. After subject recruitment and baseline assessment, the participants were followed for 6 weeks for documentation of baseline seizure frequency before receiving four biweekly intervention sessions of social support alone or with mindfulness therapy. This was followed by another 6-week period before final assessment. The assessors were blinded to the patient's group assignment. The principles of mindfulness used emphasized mind-body connection and the concept of acceptance as coping with peri-ictal disturbances.
While the QOLIE-31-P scores improved in both groups, more patients (11/30, 36.6%) in the mindfulness group experienced a clinically important improvement with score increases of at least 11.8 points than in the social support group (4/30, 13.3%; p = 0.037). As regards mood, more patients in the mindfulness group experienced a clinically significant difference in severity on the Beck Anxiety Inventory. Similarly, the authors report significant improvement in depressive symptoms, and delayed memory scores in the mindfulness group compared with the social support group. Seizure frequency was significantly reduced in the within-subject test, and there was a significant seizure reduction within-group as well, but no significant difference between the two groups.
The study is important because it illustrates the importance of targeting the quality of life as a priority in persons with intractable seizures, instead of just seizure count, reminding us of the large zone of intersection between seizures and psychiatric and cognitive comorbidities in epilepsy. The results also alert us to the potential effectiveness of nonpharmacologic interventions. In intractable epilepsy, much of the anxiety springs from the fear and unpredictability of having the next seizure. Mindfulness meditation focuses on staying in touch with the present moment, instead of succumbing to anticipatory anxiety. It is highly likely, based on this study, that there is great usefulness of mindfulness in epilepsy, which must be confirmed in larger trials. Importantly, mindfulness is also likely to help in another condition: psychogenic nonepileptic seizures, which have been shown to benefit from cognitivebehavioral therapy (6) .
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